Yunn‐Fang Ho

3.1k total citations
51 papers, 805 citations indexed

About

Yunn‐Fang Ho is a scholar working on Geriatrics and Gerontology, Molecular Biology and Pharmacology. According to data from OpenAlex, Yunn‐Fang Ho has authored 51 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Geriatrics and Gerontology, 13 papers in Molecular Biology and 13 papers in Pharmacology. Recurrent topics in Yunn‐Fang Ho's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Medication Adherence and Compliance (6 papers) and Innovations in Medical Education (5 papers). Yunn‐Fang Ho is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Medication Adherence and Compliance (6 papers) and Innovations in Medical Education (5 papers). Yunn‐Fang Ho collaborates with scholars based in Taiwan, United States and Malaysia. Yunn‐Fang Ho's co-authors include Jih‐Hwa Guh, Tung‐Hu Tsai, Shiow‐Lin Pan, F. C. Cheng, Ling-Chien Hung, Fang‐Ju Lin, Fan‐Lu Kung, Lih‐Ching Hsu, Jui‐Ling Hsu and Ming‐Chih Shih and has published in prestigious journals such as Neurology, The Journal of Urology and Journal of Chromatography A.

In The Last Decade

Yunn‐Fang Ho

49 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunn‐Fang Ho Taiwan 17 303 128 98 80 72 51 805
Cheryl L. Zimmerman United States 20 581 1.9× 177 1.4× 103 1.1× 95 1.2× 89 1.2× 63 1.4k
Nancy Van Osselaer Belgium 18 207 0.7× 207 1.6× 106 1.1× 73 0.9× 75 1.0× 30 936
Akshata Moghe United States 12 408 1.3× 88 0.7× 44 0.4× 42 0.5× 30 0.4× 30 952
Amy Price United Kingdom 6 406 1.3× 200 1.6× 302 3.1× 47 0.6× 224 3.1× 12 1.3k
Xiaoyu Qu China 19 321 1.1× 125 1.0× 176 1.8× 60 0.8× 46 0.6× 39 884
Vanessa González-Covarrubias Mexico 15 470 1.6× 134 1.0× 74 0.8× 81 1.0× 130 1.8× 43 1.0k
Srinivas Gopala India 21 572 1.9× 112 0.9× 45 0.5× 40 0.5× 21 0.3× 69 1.5k
Weihong Ge China 16 274 0.9× 84 0.7× 185 1.9× 77 1.0× 68 0.9× 58 817
Yıldız Dinçer Türkiye 18 311 1.0× 47 0.4× 30 0.3× 67 0.8× 41 0.6× 49 940
Surya Ayalasomayajula United States 20 364 1.2× 83 0.6× 44 0.4× 151 1.9× 41 0.6× 42 1.5k

Countries citing papers authored by Yunn‐Fang Ho

Since Specialization
Citations

This map shows the geographic impact of Yunn‐Fang Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunn‐Fang Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunn‐Fang Ho more than expected).

Fields of papers citing papers by Yunn‐Fang Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunn‐Fang Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunn‐Fang Ho. The network helps show where Yunn‐Fang Ho may publish in the future.

Co-authorship network of co-authors of Yunn‐Fang Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Yunn‐Fang Ho. A scholar is included among the top collaborators of Yunn‐Fang Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunn‐Fang Ho. Yunn‐Fang Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yen‐Ming, et al.. (2025). Translation and Validation of the Medication Understanding and Use Self‐Efficacy Scale Among Patients With Type 2 Diabetes in Taiwan. Health Expectations. 28(2). e70222–e70222. 1 indexed citations
2.
Huang, Yen‐Ming, et al.. (2025). Validation of the Traditional Chinese Version of the Belief About Medicines Questionnaire-Specific Among Adults with Type 2 Diabetes in Taiwan. Patient Preference and Adherence. Volume 19. 2039–2053. 1 indexed citations
3.
Chan, Hung‐Yu, et al.. (2024). Cardiometabolic biomarkers and comorbid metabolic syndrome in schizophrenia: A cross-sectional study of long-term clozapine/olanzapine users. Asian Journal of Psychiatry. 102. 104244–104244. 1 indexed citations
4.
Huang, Yen‐Ming, et al.. (2023). A Qualitative Approach to Exploring Workflow and Cost Factors of Dispensing Services in Community Pharmacies in Taiwan. Journal of Multidisciplinary Healthcare. Volume 16. 3179–3188. 2 indexed citations
5.
Huang, Yu‐Ting, et al.. (2023). Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: A focus on ontogeny impact. CPT Pharmacometrics & Systems Pharmacology. 12(12). 1960–1971. 7 indexed citations
6.
7.
Kaibara, Atsunori, Rujia Xie, Yunn‐Fang Ho, et al.. (2022). The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities. CPT Pharmacometrics & Systems Pharmacology. 11(4). 403–408. 2 indexed citations
8.
9.
Huang, Yen‐Ming, et al.. (2021). Engaging consumers in wise use of over-the-counter medications in Taiwan: Development and evaluation of a structured medication counseling approach. Patient Education and Counseling. 105(4). 942–948. 5 indexed citations
10.
Wu, Chien‐Chih, Fang‐Ju Lin, Shu‐Wen Lin, et al.. (2020). Clinical pharmacy service and international collaboration: Model and experience from a medical center in Taiwan. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(5). 959–965. 6 indexed citations
11.
Ho, Yunn‐Fang, et al.. (2018). Statin use associated with lower risk of epilepsy after intracranial haemorrhage: A population‐based cohort study. British Journal of Clinical Pharmacology. 84(9). 1970–1979. 20 indexed citations
12.
Ho, Yunn‐Fang, et al.. (2018). Comedication with interacting drugs predisposes amiodarone users in cardiac and surgical intensive care units to acute liver injury. Medicine. 97(37). e12301–e12301. 4 indexed citations
13.
Tan, Ming‐Liang, Ping Zhao, Lei Zhang, et al.. (2018). Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of HepaticCYP2C8 andOATP1B Drug Substrates. Clinical Pharmacology & Therapeutics. 105(3). 719–729. 51 indexed citations
14.
Huang, Yen‐Ming, et al.. (2016). Learning by Doing at Community Pharmacies: Objectives and Outcomes. 20(3). 144–153. 3 indexed citations
15.
Kung, Fan‐Lu, et al.. (2014). Determinants of Curricular Effectiveness for a Community Pharmacy Experiential Course. 18(3). 32–42. 1 indexed citations
16.
Wu, Fe‐Lin Lin, Yung‐Ming Chen, Tai‐Shuan Lai, et al.. (2012). Does Chinese Herb Nephropathy Account for the High Incidence of End-Stage Renal Disease in Taiwan?. Nephron Clinical Practice. 120(4). c215–c222. 12 indexed citations
17.
18.
19.
Ho, Yunn‐Fang, et al.. (2009). Lipid-mediated preferential localization of hypericin in lipid membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1788(6). 1287–1295. 57 indexed citations
20.
Ho, Yunn‐Fang, et al.. (2006). The Cognition of Chronic-Disease Refill Prescriptions of the Outpatients. 578–585. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheryl L. Zimmerman Breakdown of academic impact, for papers by Nancy Van Osselaer Breakdown of academic impact, for papers by Akshata Moghe Breakdown of academic impact, for papers by Amy Price Breakdown of academic impact, for papers by Xiaoyu Qu Breakdown of academic impact, for papers by Vanessa González-Covarrubias Breakdown of academic impact, for papers by Srinivas Gopala Breakdown of academic impact, for papers by Weihong Ge Breakdown of academic impact, for papers by Yıldız Dinçer Breakdown of academic impact, for papers by Surya Ayalasomayajula
Rankless by CCL
2026